Opérations
Qui sommes-nous ?
L’entreprise
Equipe
Nos bureaux
Globalscope
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Services
Corporate Finance
Conseil en matière de dette
Equity Research
Levées de Fonds – Séries A, B, C ….
Stratégie et préparation de l’introduction en bourse
Industries
Services aux Entreprises
Consumer / Retail / E-commerce
Technologie industrielle
Life science et Santé
Software / TMT
Career
Evénements
Insights
News
Company News
Deal News
Carlsquare in the Media
Newsletter
Contactez-nous
Newsletter
FR
INT
DA
DE
SV
Main menu button
Equipe
Opérations
Contact
Equipe
Opérations
Contact
Actualités
Tout
Company News
Deal News
Equity Research
Events
Insights
Macro and markets
Media
Tout
Abera Bioscience
All for One Group
ALM Equity
Alzecure Pharma
Angler Gaming
Arctic Minerals
Biosergen
Candles Scandinavia
Carlsquare
CDON
CellaVision
CSAM Health Group
Elicera Therapeutics
Enrad
Frequentis
Future Gaming
GHP Specialty Care
Hanza
Herantis Pharma
Immunovia
InCoax
Kancera
KlaraBo
Lohilo Foods
Lokotech
Medclair Invest
Midsummer
Modus Therapeutics
Moninvent
Nischer Properties
Nosa Plugs
Observit
Orion Corporation
Pila Pharma
Risk Intelligence
SBB i Norden
Spotlight Group
Svenska Aerogel
Teneo AI
Thinc Collective
Viva Wine Group
White Pearl Technology Group
Zinzino
Tout
26 Fév 2019
Analysis Hanza: Acquisition could lift EPS
Equity Research
25 Fév 2019
Analysis, GHP: Recovery in 2018 bodes well
Equity Research
25 Fév 2019
Analysis Ecoclime: Increased sales focus aimed at property owners
Equity Research
22 Fév 2019
Analysis Mytaste: International expansion to drive growth
Equity Research
22 Fév 2019
Analysis Netmore: New companies adds potential
Equity Research
21 Fév 2019
Analysis Multidocker: Good order intake, weak result though
Equity Research
20 Fév 2019
Analysis Aspire: Growth continues...
Equity Research
20 Fév 2019
Analysis Miris: Expected growth in the US
Equity Research
19 Fév 2019
Analysis, Alligator: Hunting new deals
Equity Research
18 Fév 2019
Analysis FastPartner: Additional value and capital gains
Equity Research
14 Fév 2019
Analysis Precise Biometrics: No break-through until year 2020
Equity Research
14 Fév 2019
Analysis, Verisec: Security for the future
Equity Research
13 Fév 2019
Analysis Serneke: Construction back into profitability, focus on Karlastaden
Equity Research
13 Fév 2019
Analysis, Coor: Pressure from new contracts
Equity Research
12 Fév 2019
Analysis, Gunnebo: There are positive signs
Equity Research
11 Fév 2019
Analysis, Kancera: Constructive steps
Equity Research
06 Fév 2019
Analysis Lammhults: Solid export growth, somewhat weaker in Sweden
Equity Research
23 Jan 2019
Analysis, NeuroVive: Raising capital for clinical trials
Equity Research
23 Jan 2019
Eq Research Serneke: Nice property deals- focus on Construction profits
Equity Research
16 Jan 2019
Analysis Gunnebo: Better without France
Equity Research
1
…
47
48
49
50
51
…
64